{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-26-007845","form_type":"8-K","ticker":"SBFM","cik":"0001402328","company_name":"Sunshine Biopharma Inc.","filed_at":"2026-10-14T20:05:13+00:00","discovered_at":"2026-10-14T20:06:00.232530+00:00","generated_at":"2026-10-14T20:06:07.347325+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"negative","materiality_score":0.55,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Sunshine Biopharma CEO's 90% consent approves discounted share issuance and Series D warrant repricing","bullets":["Dr. Steve N. Slilaty, CEO and holder of ~90% of voting power, approved the matters by written consent on October 13, 2026.","Consent covers issuing more than 20% of outstanding common stock at a deemed discount to the Nasdaq Minimum Price, tied to the public offering that closed October 9, 2026.","Also approves exercise-price/share-count adjustments to Series D Warrants in a Share Combination Event (Section 3.7) and voluntary repricing of all outstanding Series D Warrants (Section 3.8).","Consent becomes effective 20 days after the definitive information statement is mailed to stockholders.","Common stock trades as SBFM and the purchase warrants as SBFMW on Nasdaq."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-26-007845","json":"https://secwatch.observer/filing/0001683168-26-007845.json","markdown":"https://secwatch.observer/filing/0001683168-26-007845.md","text":"https://secwatch.observer/filing/0001683168-26-007845.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1402328/000168316826007845/0001683168-26-007845-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1402328/000168316826007845/sunshine_8k.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-10-14T20:06:07.347325+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}